Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation
oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]
AI Summary: The FDA has ushered in a new era in oncology drug oversight by appointing Dr. Richard Pazdur as the director of its Drug Center. The move comes amid agency challenges and staff cuts, promising stabilizing leadership at one of its most influential divisions.
Related Stories
FDA clears first new sunscreen ingredient in two decades / 28 days
FDA commissioner Marty Makary resigns amid mounting scrutiny / 1 month
FDA Abortion Pill Decisions Rooted in Science / 5 months
FDA loosens data restrictions to accelerate drug reviews / 6 months
FDA links eight deaths to Amgen’s Tavneos; scrutiny intensifies / 3 months
FDA approves leucovorin for rare folate disorder despite autism hype / 3 months
FDA launches individualized therapy framework for ultra-rare diseases / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Supplements, Behavioral Health, Hospital Operations, Animal Health and look for the RSS link.
StackHealth Time Machine